Anders Ulfhielm will as of September 22, 2016 take over as CEO for Nicoccino Holding AB. He has long experience in the pharmaceutical industry, most recently from a position as partner at Avanticon AB. The change is part of Nicoccino’s strategic focus in achieving a drug approval of the product that was announced this spring. The current CEO, Johan Cram, will thereby leave Nicoccino Holding AB.